Delivery Order SPE2DB24D9223-SPE2DB25FKEMS
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $18,637.55 by the Defense Logistics Agency on July 29, 2025, for the supply of Photrexa Cross-Linking Kit 6ML. This firm fixed-price delivery order is expected to be completed by August 19, 2025, and will be performed at the contractor's Park Ridge, Illinois facility. The award carries no set-aside designation, allowing DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Photrexa Cross-Linking Kit 6ml. This firm fixed-price delivery order, valued at $37,275.10, is scheduled for completion by October 2, 2025, with performance taking place in Park Ridge, Illinois. The award was made without a set-aside designation, allowing the vendor to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,727.51 by the Defense Logistics Agency (DLA) on August 13, 2025. The contract calls for delivery of a Photrexa Cross-Linking Kit (6ml), a specialized pharmaceutical product, with an ultimate completion date of September 4, 2025. This delivery order was issued without a set-aside designation, allowing the vendor to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $22,233.54 by the Defense Logistics Agency on September 24, 2025, for the supply of Photrexa Cross-Linking Kit 6ml. The award is structured as a firm fixed-price delivery order with an ultimate completion date of October 16, 2025, and no set-aside designation was utilized in the procurement. This delivery order falls under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $18,637.55 by the Defense Logistics Agency for the supply of Photorexa Cross-Linking Kit 6ml. This firm fixed-price delivery order, issued on August 27, 2025, with an ultimate completion date of September 18, 2025, represents a specific medical product fulfillment under the company's broader pharmaceutical supply agreement with the...
- The Defense Logistics Agency (DLA) awarded a $7,455.02 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of a Photrexa Cross-Linking Kit (6ml). This firm fixed-price delivery order, issued on September 10, 2025, with an ultimate completion date of October 1, 2025, carries no set-aside designation. The award represents a single delivery order issued under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a $11,182.53 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for the supply of Photorexa Cross-Linking Kit 6ml, a pharmaceutical product for federal healthcare use. The delivery order was issued on July 23, 2025, with an ultimate completion date of August 13, 2025, and performance will be fulfilled from the contractor's facility in Park Ridge, Illinois. No set-aside designation was applied to this procurement. DMS Pharmaceutical Group Inc., a...
- The Defense Logistics Agency awarded a delivery order valued at $7,455.02 to DMS Pharmaceutical Group Inc. for the supply of Photrexa Cross-Linking Kit (6ml). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected to provide this pharmaceutical product with a firm fixed-price contract type. The delivery order carries an ultimate completion date of July 10, 2025, and was awarded on June 17, 2025, with no set-aside...
- The U.S. Defense Logistics Agency (DLA) awarded a $26,555.36 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for PHOTREXA CROSS-LINKING KITS, which are medical devices used in ophthalmic procedures. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC allows the DLA to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,007.42, is to provide the PHOTREXA CROSS-LINKING KIT 6ML, a pharmaceutical product, to support the recurring medical supply needs of military health facilities worldwide. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up...
- SPE2DB24D9223Indefinite Delivery Contract
- SPE2DB24D9223-SPE2DB25FKEMSDelivery Order
The Defense Logistics Agency awarded a $14,822.36 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on September 24, 2025. The delivery order, which must be completed by October 16, 2025, is for the supply of Photrexa Cross-Linking Kit (6ml), a specialized pharmaceutical product. This award was made without a set-aside designation, reflecting the company's competitive standing in the federal pharmaceutical procurement market. The place of performance is located in Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its operations. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499,999,999 and valid through November 2026. The IDC, designated under the SPE2DB program, enables the agency to procure a comprehensive range of pharmaceutical products to support medical supply needs across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, consistently delivering branded and generic prescription drugs, biologics, and medical consumables to military health facilities. The company's contract portfolio demonstrates substantial federal procurement experience, with previous awards covering diverse pharmaceutical products including specialty medications, vaccines, and oncology treatments.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.8k | 9/24/25 |